Informed consent form
The document that explains the study, the expected benefits and the risks. You only take part after reading it, asking questions and signing it.
Clinical research
Before it reaches those who need it, a treatment is studied with people who chose to take part. This is how medicine advances, with clear rules to protect each participant.
The stages
Each phase answers a question. A treatment only moves forward when the previous phase gave a good answer.
Phase 1
The first assessments in people. A small group helps define the dose and observe how the body reacts.
Phase 2
A larger group, with the disease to be treated, shows whether the treatment has an effect and continues to assess safety.
Phase 3
Hundreds or thousands of participants, at several centers. The new treatment is compared with the standard treatment.
Phase 4
After approval, the treatment continues to be monitored in wider use, for longer and in more people.
Your rights
The document that explains the study, the expected benefits and the risks. You only take part after reading it, asking questions and signing it.
An independent group that reviews each study before it starts and follows it to the end, always on the participant's side.
In Brazil, studies of new medicines are also reviewed by Anvisa, the health regulatory agency, and by the national research ethics system.
The international standard that defines how a study must be conducted, recorded and verified.
How to take part
By phone, by message or through your doctor. We answer your first questions, with no commitment.
We check whether there is an open study that may be suitable and explain the criteria.
You receive the information in writing, take it home, talk to your family and only take part if you want to.
Study visits, tests and treatment, with the team by your side at every step.
Myths and facts
Myth
Participants have guaranteed rights, are informed of everything before deciding and are followed by a team and by an independent ethics committee.
Myth
There are studies for different moments of treatment, including for people who have just been diagnosed.
Myth
You can leave whenever you want, without explaining why, and you remain entitled to your care.
Fact
Every approved medicine exists because people agreed to take part in the studies that showed it works.
Common questions
Each study has its own criteria, such as the type and stage of the disease, previous treatments and the results of some tests. The medical team assesses each case and explains the reason when a study is not suitable.
No. Study visits, tests and medicines are free of charge for the participant. Expenses related to the visits, such as transport and meals, may be reimbursed, as provided for in each study.
Yes. Participation is voluntary. You can leave at any time, without having to explain why and with no effect on your medical care.
It depends on the study, and this is explained before you decide. In oncology, when an effective treatment exists, the participant is not left without treatment: the study compares the new treatment with the standard treatment, or combines the two.
Every treatment has possible benefits and risks, and both are explained before you decide. A study only starts after it has been approved by a Research Ethics Committee and by the regulatory authorities, and participants are followed closely throughout.
Yes. Taking part in a study does not replace your doctor. Keep your doctor informed; with your permission, the study team will talk to them.
Yes. The information is confidential. In the study records, each participant is identified by a code, and the data is handled under Brazil's General Data Protection Law (LGPD).
Talk to our team or ask your doctor to contact us. With some information about your diagnosis, we check whether there is an open study that may be suitable.
The team explains calmly, as many times as needed. The conversation creates no commitment.